Press coverage about CorVel (NASDAQ:CRVL) has trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CorVel earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news headlines about the business services provider an impact score of 45.5060484685781 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Separately, BidaskClub upgraded shares of CorVel from a “hold” rating to a “buy” rating in a report on Tuesday, March 13th.
Shares of NASDAQ CRVL traded up $52.10 during midday trading on Friday, hitting $52.10. The stock had a trading volume of 12,400 shares, compared to its average volume of 32,689. The company has a market cap of $977.98 million, a PE ratio of 28.46 and a beta of 0.70. CorVel has a 52 week low of $51.90 and a 52 week high of $51.90.
CorVel Company Profile
CorVel Corporation provides medical cost containment and managed care services to address the medical costs of workers' compensation benefits, automobile insurance claims, and group health insurance benefits. The company offers network solutions, including automated medical fee auditing, preferred provider management and reimbursement services, retrospective utilization review, facility claim review, professional review, pharmacy services, directed care services, medicare solutions, clearinghouse services, independent medical examinations, and inpatient medical bill review.
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.